Evidence map›Paper›PMID 35287291›Full record

ArticleJHEP reports : innovation in hepatology2022

Swelling-induced upregulation of miR-141-3p inhibits hepatocyte proliferation.

Nils Bardeck, Martha Paluschinski, Mirco Castoldi, Claus Kordes, Boris Görg, Jan Stindt, Tom Luedde, Stephan Vom Dahl, Dieter Häussinger, David Schöler

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Antihypertensive Therapy and Incidence of Cancer.Journal of clinical medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Nils BardeckDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Martha PaluschinskiDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Mirco CastoldiDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Claus KordesDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Boris GörgDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Jan StindtDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Tom LueddeDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Stephan Vom DahlDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Dieter HäussingerDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
David SchölerDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University Hospital, Düsseldorf, Germany.
Düsseldorf University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: MicroRNAs (miRNAs) act as a regulatory mechanism on a post-transcriptional level by repressing gene transcription/translation and play a central role in the cellular stress response. Osmotic changes occur in a variety of diseases including liver cirrhosis and hepatic encephalopathy. Changes in cell hydration and alterations of the cellular volume are major regulators of cell function and gene expression. In this study, the modulation of hepatic gene expression in response to hypoosmolarity was studied. Methods: mRNA analyses of normo- and hypoosmotic perfused rat livers by gene expression arrays were used to identify miRNA and their potential target genes associated with cell swelling preceding cell proliferation. Selected miR-141-3p was also investigated in isolated hepatocytes treated with miRNA mimic, cell stretching, and after partial hepatectomy. Inhibitor perfusion studies were performed to unravel signalling pathways responsible for miRNA upregulation. Results: Using genome-wide transcriptomic analysis, it was shown that hypoosmotic exposure led to differential gene expression in perfused rat liver. Moreover, miR-141-3p was upregulated by hypoosmolarity in perfused rat liver and in primary hepatocytes. In concert with this, miR-141-3p upregulation was prevented after Src-, Erk-, and p38-MAPK inhibition. Furthermore, luciferase reporter assays demonstrated that miR-141-3p targets cyclin dependent kinase 8 ( Conclusions: Src-mediated upregulation of miR-141-3p was found in hepatocytes in response to hypoosmotic swelling and mechanical stretching. Because of its antiproliferative function, miR-141-3p may counter-regulate the proliferative effects triggered by these stimuli. Lay summary: In this study, we identified microRNA 141-3p as an osmosensitive miRNA, which inhibits proliferation during liver cell swelling. Upregulation of microRNA 141-3p, controlled by Src-, Erk-, and p38-MAPK signalling, results in decreased mRNA levels of various genes involved in metabolic processes, macromolecular biosynthesis, and cell cycle progression.

Indexed as

Camsap1, calmodulin-regulated spectrin-associated protein 1Cdc25a, cell division cycle 25ACdk8, cyclin dependent kinase 8ColchicineCpt2, carnitine palmitoyl transferase 2Dmxl1, Dmx Like 1Dstyk, dual serine/threonine and tyrosine protein kinaseDuoxa2, dual oxidase maturation factor 2ECM, extracellular matrixEml4, EMAP like 4GO, gene ontologyGucy2c, guanylate cyclase 2CHepatocytesHypoosmolarityLiver perfusionLiver regenerationLuc7l3, LUC7 like 3 pre-MRNA splicing factormicroRNAmiR-141-3pmiRNA, microRNAMsantd2, Myb/SANT DNA binding domain containing 2Nags, N-acetyl glutamate synthaseNfat5, nuclear factor of activated t cells 5OsmosisPHxPHx, partial hepatectomyPI, propidium iodidePrmt1, protein arginine methyltransferase 1qPCR, quantitative PCRRab30, member RAS Oncogene FamilyRps6, ribosomal Protein S6RT, room temperatureScnn1a, sodium channel epithelial 1 subunit alphaSlc39a10, solute carrier family 39 member 10Tfeb, transcription factor EBTimp1, tissue inhibitor of metalloproteinase 1Zmpste24, zinc metallopeptidase STE24

Identifiers

PMID35287291
PMCPMC8917307
OpenAlexW4207012361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.